Thromboembolic Complications in Mild Covid-19 Cases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

961 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-01

Study Completion Date

2022-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to investigate the frequency of thromboembolic complications and the factors influencing them in COVID-19 cases that did not require hospitalization. For this purpose, patients registered at two different family health centers in Istanbul were retrospectively screened, and their status regarding post-COVID-19 thromboembolic events was recorded. The sociodemographic characteristics, medical history, COVID-19 treatments received, comorbidities, and current medications of all patients were examined and compared with the occurrence of complications.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic

NCT04400877

COVID-19 Venous Thromboembolism Pulmonary Embolism +2 more

COMPLETED

Thrombosis and Covid-19

NCT04366778

Thrombosis Covid-19 SARS-CoV 2

COMPLETED

Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications

NCT04780295

Covid19

COMPLETED

Analysis of the Coagulopathy Developed by COVID-19 Infected Patients

NCT04356950

Sepsis Blood Coagulation Disorders Thrombin +2 more

COMPLETED

Unleash the Mystery of COVID-19 Related Unusual Thrombosis

NCT05068375

COVID-19

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Studies on COVID-19 complications in the literature have predominantly focused on patients treated in hospitals, particularly in intensive care units. Data on patients with mild to moderate symptoms who were followed up on an outpatient basis in primary care are quite limited. Therefore, our research investigated the incidence of thrombotic events within six months following infection in mild to moderate COVID-19 cases and the factors that might influence these events. Records of 961 individuals registered at two different family health centers in Istanbul were reviewed. Patients were contacted by phone, informed about the study, and data regarding their sociodemographic characteristics, medical histories, COVID-19 infection experiences, and medications used were collected. Comparative analyses (Fisher's exact test) and logistic regression tests were conducted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID 19 Thromboembolic and Bleeding Complications Thromboembolism, Venous Post COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with a PCR-confirmed COVID-19 diagnosis who were followed up on an outpatient basis

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being over 18 years of age
* Having had a confirmed COVID-19 infection verified by a PCR test
* Being monitored at a family health center without requiring hospitalization during the COVID-19 course
* Having at least 6 months elapsed since the infection
* Availability of the patient's medical records
* Absence of any language barrier or health issue that would prevent communication with the patient

Exclusion Criteria

* Being under 18 years of age
* Having had less than 6 months since the COVID-19 infection
* Presence of any condition that prevents communication with the patient
* Incomplete or missing medical records of the patient
* History of hospitalization due to COVID-19 infection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes